|
FRAS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.99969946052181E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09789963179219E-10 |
| Normal-vs-Stage2 |
1.57825999999028E-05 |
| Normal-vs-Stage3 |
7.800200E-03 |
| Normal-vs-Stage4 |
7.019600E-01 |
| Stage1-vs-Stage2 |
4.868400E-01 |
| Stage1-vs-Stage3 |
2.323800E-01 |
| Stage1-vs-Stage4 |
3.361200E-01 |
| Stage2-vs-Stage3 |
6.188600E-01 |
| Stage2-vs-Stage4 |
4.273400E-01 |
| Stage3-vs-Stage4 |
5.524200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60169988383529E-10 |
| Normal-vs-AfricanAmerican |
4.178400E-04 |
| Normal-vs-Asian |
3.425300E-04 |
| Caucasian-vs-AfricanAmerican |
1.417630E-01 |
| Caucasian-vs-Asian |
8.254000E-01 |
| AfricanAmerican-vs-Asian |
5.062800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.48434606220371E-12 |
| Normal-vs-Female |
7.319100E-03 |
| Male-vs-Female |
5.097200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.790700E-04 |
| Normal-vs-Extreme_Weight |
7.89723841876366E-12 |
| Normal-vs-Obese |
8.48150000000158E-05 |
| Normal-vs-Extreme_Obese |
1.94966999998991E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.841370E-01 |
| Normal_Weight-vs-Obese |
8.706200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.172600E-01 |
| Extreme_Weight-vs-Obese |
5.168400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.920400E-01 |
| Obese-vs-Extreme_Obese |
2.817800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.66109999977238E-07 |
| Normal-vs-Age(41-60Yrs) |
2.14499999995343E-06 |
| Normal-vs-Age(61-80Yrs) |
1.16410214801022E-11 |
| Normal-vs-Age(81-100Yrs) |
6.365900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.792500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.294000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.729200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.120480E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.037600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.430600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.06923367329637E-12 |
| Normal-VS-Type2 PRCC |
3.85550000003843E-06 |
| Normal-VS-KIRP CIMP |
2.084600E-01 |
| Normal-VS-Unclassified PRCC |
1.603620E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.230000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.096600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.162600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.490800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.533200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.376000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29540000004535E-06 |
| Normal-vs-N1 |
1.762370E-02 |
| Normal-vs-N2 |
7.865200E-01 |
| N0-vs-N1 |
4.543400E-01 |
| N0-vs-N2 |
3.768800E-01 |
| N1-vs-N2 |
1.896830E-01 |
|
|
